Clinical immunologic interventions for the treatment of type 1 diabetes.
about
The impact of rare and low-frequency genetic variants in common diseasePreexisting insulin autoantibodies predict efficacy of otelixizumab in preserving residual β-cell function in recent-onset type 1 diabetesPrimary and secondary prevention of Type 1 diabetesReestablishing T Cell Tolerance by Antibody-Based Therapy in Type 1 Diabetes.
P2860
Clinical immunologic interventions for the treatment of type 1 diabetes.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical immunologic interventions for the treatment of type 1 diabetes.
@en
type
label
Clinical immunologic interventions for the treatment of type 1 diabetes.
@en
prefLabel
Clinical immunologic interventions for the treatment of type 1 diabetes.
@en
P2860
P1476
Clinical immunologic interventions for the treatment of type 1 diabetes.
@en
P2093
Anette-G Ziegler
P2860
P356
10.1101/CSHPERSPECT.A007716
P577
2012-08-01T00:00:00Z